Physician profile
Francis E Harman
NPI 1245232495
$588.54
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $139 · 2021: $148 · 2023: $21.52 · 2024: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $188.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $143.72 | 2019-2021 | |
| Spinal Simplicity, LLC | $95.90 | 2024 | Ha Minuteman G3-R |
| Pfizer INC. | $86.29 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $70.96 | 2024 | Gvoke Hypopen |
| Amarin Pharma, INC. | $29.04 | 2020-2021 | |
| Lilly USA, LLC | $28.72 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $21.52 | 2023 | Evusheld |
| Daiichi Sankyo INC. | $19.21 | 2020 | |
| Allergan, INC. | $18.67 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $16.71 | 2019 | |
| Novo Nordisk INC | $16.43 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $16.26 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.96 | 2021 | |
| Stryker Corporation | $12.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francis Harman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.